Mura J, Rojas-Zalazar D, Ruíz A, Vintimilla L C, Marengo J J
Institute of Neurosurgery Asenjo, Santiago, Chile.
Minim Invasive Neurosurg. 2007 Dec;50(6):355-62. doi: 10.1055/s-2007-993201.
Cisternal and ventricular blood predisposes to hydrocephalus and cerebral ischemia after high-grade aneurysmal subarachnoid hemorrhage (HGSAH). We studied the role of lamina terminalis fenestration combined with cisternal blood evacuation in HGSAH.
PATIENTS/MATERIALS AND METHODS: A clinical, prospective, non-randomized study of a series of HGSAH patients (Modified Fisher>or=3) treated in the acute phase was carried out. The microsurgical treatment included aneurysm clipping, cisternal blood evacuation, and fenestration of the lamina terminalis. A comparable, non-blood-cleansed, endovascular-treated group, was included as a control. Clinical results were evaluated by the Glasgow Outcome Scale (GOS).
During a period of 30 months, 95 patients who met the selection criteria were treated by microsurgical procedures and 28 by endovascular procedures. The distribution of GOS scores was superior for the microsurgical group: good results (GOS 4-5) were obtained in 85.3%, with a mortality rate of 5.9%. By contrast, 60.3% of patients in the endovascular group achieved GOS 4-5 scores, and 15.8% died. Good results for the endovascular group correlated inversely with delay of treatment. A permanent ventriculo-peritoneal shunt was necessary in 3.2% and 7.1% of the microsurgical and endovascular groups, respectively. The incidence of cerebral infarct was 3.1% and 14.3% for the microsurgical and endovascular groups, respectively.
Microsurgical management reduces the usually poor outcome of patients with HGSAH. Lamina terminalis fenestration diminishes the incidence of shunt-dependent hydrocephalus and, combined with extensive cisternal blood cleansing, can lower the incidence of stroke. A procedure for cleansing blood and clots from the cisterns in HGSAH, based on the pathophysiology of vasospasm, is proposed.
在高级别动脉瘤性蛛网膜下腔出血(HGSAH)后,脑池和脑室积血易导致脑积水和脑缺血。我们研究了终板造瘘联合脑池积血清除术在HGSAH中的作用。
患者/材料与方法:对一系列急性期治疗的HGSAH患者(改良Fisher分级≥3级)进行了一项临床、前瞻性、非随机研究。显微手术治疗包括动脉瘤夹闭、脑池积血清除和终板造瘘。将一个可比的、未进行血液清除的血管内治疗组作为对照。临床结果采用格拉斯哥预后量表(GOS)进行评估。
在30个月的时间里,95例符合入选标准的患者接受了显微手术治疗,28例接受了血管内治疗。显微手术组的GOS评分分布更优:85.3%的患者获得了良好结果(GOS 4 - 5分),死亡率为5.9%。相比之下,血管内治疗组60.3%的患者GOS评分为4 - 5分,15.8%的患者死亡。血管内治疗组的良好结果与治疗延迟呈负相关。显微手术组和血管内治疗组分别有3.2%和7.1%的患者需要永久性脑室 - 腹腔分流术。显微手术组和血管内治疗组的脑梗死发生率分别为3.1%和14.3%。
显微手术治疗可改善HGSAH患者通常较差的预后。终板造瘘可降低分流依赖性脑积水的发生率,与广泛的脑池积血清除相结合,可降低中风的发生率。基于血管痉挛的病理生理学,提出了一种清除HGSAH患者脑池内血液和血凝块的方法。